Dr. David Michael Pencarinha is a Bartlett, Tennessee based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. David Michael Pencarinha is 0000012159 for Oral and Maxillofacial Surgery in Tennessee. His current practice location is 6425 Stage Rd Ste 1, Bartlett. Patients can reach him at 901-754-8002.
Dr. David Michael Pencarinha deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. David Michael Pencarinha speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1164043329
NPI Enumeration Date:
29 Apr, 2020
NPI Last Update On:
30 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. David Michael Pencarinha are as mentioned below.
License Number
Specialization
State
Status
0000012159
Oral and Maxillofacial Surgery
Tennessee
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
715 Oaklawn, Marion, Arkansas
Zip:
72364-9026
Phone Number:
423-276-7459
Patients can reach Dr. David Michael Pencarinha at 6425 Stage Rd Ste 1, Bartlett, Tennessee or can call to book an appointment on 901-754-8002. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.